The Role of Adenosine Receptors in Psychostimulant Addiction
Overview
Affiliations
Adenosine receptors (AR) are a family of G-protein coupled receptors, comprised of four members, named A, A, A, and A receptors, found widely distributed in almost all human body tissues and organs. To date, they are known to participate in a large variety of physiopathological responses, which include vasodilation, pain, and inflammation. In particular, in the central nervous system (CNS), adenosine acts as a neuromodulator, exerting different functions depending on the type of AR and consequent cellular signaling involved. In terms of molecular pathways and second messengers involved, A and A receptors inhibit adenylyl cyclase (AC), through G proteins, while A and A receptors stimulate it through G proteins. In the CNS, A receptors are widely distributed in the cortex, hippocampus, and cerebellum, A receptors are localized mainly in the striatum and olfactory bulb, while A and A receptors are found at low levels of expression. In addition, AR are able to form heteromers, both among themselves (e.g., A/A), as well as with other subtypes (e.g., A/D), opening a whole range of possibilities in the field of the pharmacology of AR. Nowadays, we know that adenosine, by acting on adenosine A and A receptors, is known to antagonistically modulate dopaminergic neurotransmission and therefore reward systems, being A receptors colocalized in heteromeric complexes with D receptors, and A receptors with D receptors. This review documents the present state of knowledge of the contribution of AR, particularly A and A, to psychostimulants-mediated effects, including locomotor activity, discrimination, seeking and reward, and discuss their therapeutic relevance to psychostimulant addiction. Studies presented in this review reinforce the potential of A agonists as an effective strategy to counteract psychostimulant-induced effects. Furthermore, different experimental data support the hypothesis that A/D heterodimers are partly responsible for the psychomotor and reinforcing effects of psychostimulant drugs, such as cocaine and amphetamine, and the stimulation of A receptor is proposed as a potential therapeutic target for the treatment of drug addiction. The overall analysis of presented data provide evidence that excitatory modulation of A and A receptors constitute promising tools to counteract psychostimulants addiction.
Ngo H, Srivastava A, Le H, Ayer S, Crotty G, Schwarzschild M BMC Neurosci. 2025; 26(1):19.
PMID: 40038582 PMC: 11877714. DOI: 10.1186/s12868-025-00939-7.
Akyuz E, Arulsamy A, Aslan F, Sarisozen B, Guney B, Hekimoglu A Mol Neurobiol. 2024; 62(2):1631-1674.
PMID: 39012443 PMC: 11772559. DOI: 10.1007/s12035-024-04333-y.
Caffeine Inhibits Both Basal and Insulin-Activated Urate Transport.
Mandal A, Merriman T, Choi H, Mount D Arthritis Rheumatol. 2024; 76(11):1658-1669.
PMID: 38932509 PMC: 11562663. DOI: 10.1002/art.42940.
Adenosine A and dopamine D receptor interaction controls fatigue resistance.
Alves A, Santos N, Santos A, da Panatta G, Speck A, Cunha R Front Pharmacol. 2024; 15:1390187.
PMID: 38860172 PMC: 11163034. DOI: 10.3389/fphar.2024.1390187.
Ngo H, Le H, Ayer S, Crotty G, Schwarzschild M, Bakshi R Res Sq. 2024; .
PMID: 38562908 PMC: 10984011. DOI: 10.21203/rs.3.rs-4076333/v1.